Clinical evaluation of multiple sclerosis:: quantification by use of scales

被引:6
|
作者
Izquierdo, G [1 ]
Ruiz-Peña, JL [1 ]
机构
[1] Hop Univ Virgen Macarena, Serv Neurol, Unidad Esclerosis, E-41009 Seville, Spain
关键词
clinical evaluation; cognitive impairment; EDSS; fatigue; multiple sclerosis; functional composite; scales;
D O I
10.33588/rn.3602.2002350
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Clinical evaluation is indispensable in multiple sclerosis (MS)for the quantitative measurement of the extent of the disorder, which is in turn required to find out how the disease is evolving and the influence the different forms of treatment are having on it, both in the experimental phase and in the usual monitoring they are subjected to. Method We review the different scales that are used to evaluate the distinct symptomatic and functional aspects of MS and the repercussions these have on the extent of disability displayed in the patient's social and personal life. Although in recent years, the EDSS has been an essential, irreplaceable scale in MS, other instruments of measurement that complement it have also begun to appear. The fatigue, cognitive function and quality of life scales are being used more and more frequently. The Multiple Sclerosis Functional Composite is an instrument that is used more and more frequently in MS and has proved to be highly sensitive in the evaluation of very important clinical trials. Conclusions. The lack of correlation between the distinct scales corroborates the fact that they measure complementary aspects of MS.
引用
收藏
页码:145 / 152
页数:8
相关论文
共 50 条
  • [31] Whole brain volume quantification in multiple sclerosis: ready for translation into clinical practice?
    Beadnall, Heidi
    Wang, Chenyu
    Burke, Therese
    Oliver, Ruth
    Hatton, Sean
    Barton, Joshua
    Ly, Linda
    Vucic, Steve
    Barnett, Michael
    NEUROLOGY, 2016, 86
  • [32] "Absolute" quantification in Magnetic Resonance Spectroscopy: validation of a clinical protocol in multiple sclerosis
    Bagory, Matthieu
    Durand-Dubief, Francoise
    Ibarrola, Danielle
    Confavreux, Christian
    Sappey-Marinie, Dominique
    2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-16, 2007, : 3458 - +
  • [33] Whole brain volume quantification in multiple sclerosis: ready for translation into clinical practice?
    Beadnall, Heidi
    Wang, Chenyu
    Burke, Therese
    Oliver, Ruth
    Hatton, Sean
    Barton, Joshua
    Ly, Linda
    Vucic, Steve
    Barnett, Michael
    NEUROLOGY, 2016, 86
  • [34] Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis
    Derakhshan, Mishkin
    Caramanos, Zografos
    Giacomini, Paul S.
    Narayanan, Sridar
    Maranzano, Josefina
    Francis, Simon J.
    Arnold, Douglas L.
    Collins, D. Louis
    NEUROIMAGE, 2010, 52 (04) : 1261 - 1267
  • [35] Gait quantification in multiple sclerosis: A single-centre experience of systematic evaluation
    Decavel, Pierre
    Sagawa, Yoshimasa, Jr.
    NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY, 2019, 49 (02): : 165 - 171
  • [36] Use of clinical scales
    Hobart, J
    KEY ADVANCES IN THE EFFECTIVE MANAGEMENT OF MULTIPLE SCLEROSIS, 1999, : 27 - 30
  • [37] Quantification of retinal vessels in multiple sclerosis
    Kadas, E. M.
    Bilger, F.
    Ludin, L.
    Oberwahrenbrock, T.
    Brandt, A. U.
    Paul, F.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 261 - 261
  • [38] Quantification of Visual Fixation in Multiple Sclerosis
    Bijvank, Jenny A. Nij
    Petzold, Axel
    Coric, Danko
    Tan, H. Stevie
    Uitdehaag, Bernard M. J.
    Balk, Lisanne J.
    van Rijn, Laurentius J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (05) : 1372 - 1383
  • [39] Brain atrophy quantification in multiple sclerosis
    Jain, S.
    Smeets, D.
    Sima, D. M.
    Ribbens, A.
    Janssens, K.
    Daams, M.
    Steenwijk, M.
    Vrenken, H.
    Barkhof, F.
    Van Hecke, W.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 283 - 284
  • [40] The Performance Scales disability measure for multiple sclerosis: use and sensitivity to clinically important differences
    Carolyn E. Schwartz
    Victoria E. Powell
    Health and Quality of Life Outcomes, 15